These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 5167160)

  • 1. Consummatory behavior during tolerance to and withdrawal from chronic depression of cholinesterase activity.
    Russell RW; Vasquez BJ; Overstreet DH; Dalglish FW
    Physiol Behav; 1971 Oct; 7(4):523-8. PubMed ID: 5167160
    [No Abstract]   [Full Text] [Related]  

  • 2. Stimulus control during chronic reduction of cholinesterase activity.
    Warburton DM; Segal DS
    Physiol Behav; 1971 Oct; 7(4):539-43. PubMed ID: 5131211
    [No Abstract]   [Full Text] [Related]  

  • 3. Reduced behavioral effects of pilocarpine during chronic treatment with DFP.
    Overstreet DH
    Behav Biol; 1974 May; 11(1):49-58. PubMed ID: 4833225
    [No Abstract]   [Full Text] [Related]  

  • 4. The effects of pilocarpine on the drinking behavior of rats following acute and chronic treatment with diisopropylfluorophosphate and during withdrawal.
    Overstreet DH
    Behav Biol; 1973 Aug; 9(2):257-63. PubMed ID: 4721219
    [No Abstract]   [Full Text] [Related]  

  • 5. Memory access pathway: role of adrenergic versus cholinergic neurons.
    Hamburg MD; Cohen RP
    Pharmacol Biochem Behav; 1973; 1(3):295-300. PubMed ID: 4775859
    [No Abstract]   [Full Text] [Related]  

  • 6. Cholinesterase activity of human plasma after intramuscular diisopropyl fluorophosphonate (DFP).
    MUNKNER T; MATZKE J; VIDEBAEK A
    Acta Pharmacol Toxicol (Copenh); 1961; 18():170-4. PubMed ID: 14477221
    [No Abstract]   [Full Text] [Related]  

  • 7. Involvement of muscarinic and nicotinic receptors in behavioral tolerance to DFP.
    Overstreet DH; Russell RW; Vasquez BJ; Dalglish FW
    Pharmacol Biochem Behav; 1974; 2(1):45-54. PubMed ID: 4828482
    [No Abstract]   [Full Text] [Related]  

  • 8. The absence of sympathetic role in anti-ChE-induced changes in cholinergic transmission.
    Bito LZ
    J Pharmacol Exp Ther; 1968 Jun; 161(2):302-9. PubMed ID: 4297029
    [No Abstract]   [Full Text] [Related]  

  • 9. Changes in peripheral cholinergic systems following development of tolerance to the anticholinesterase diisopropylfluorophosphate.
    Carson VG; Jenden DJ; Russell RW
    Toxicol Appl Pharmacol; 1973 Sep; 26(1):39-48. PubMed ID: 4748137
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of di-isopropylfluorophosphate on the neuro-muscular transmission and the importance of cholinesterase for the transmission of single impulses.
    BARSTAD JA
    Arch Int Pharmacodyn Ther; 1956 Jul; 107(1):21-32. PubMed ID: 13341143
    [No Abstract]   [Full Text] [Related]  

  • 11. Withdrawal in the rat after long-term forced oral barbital administration.
    Wahlström G
    Acta Pharmacol Toxicol (Copenh); 1974 Aug; 35(2):131-44. PubMed ID: 4479394
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of withdrawal from chronic amphetamine administration on activity levels of albino rats.
    Houser VP; Van Hart DA
    Psychol Rep; 1974 Aug; 35(1):307-10. PubMed ID: 4472602
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of intravitreous injection of drugs on the cholinesterase of the retina.
    Rose S; Glow PH
    Aust J Exp Biol Med Sci; 1965 Dec; 43(6):737-42. PubMed ID: 4287193
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of partial postganglionic parasympathetic and sympathetic denervation on the acetylcholine content and cholinesterase activity in submandibular salivary gland tissue].
    Gutkin VI
    Fiziol Zh SSSR Im I M Sechenova; 1971 Jan; 57(1):90-4. PubMed ID: 5554065
    [No Abstract]   [Full Text] [Related]  

  • 15. Relationship between behavioral changes and brain cholinesterase activity following graded intracerebral injections of DFP.
    WHITE RP
    Proc Soc Exp Biol Med; 1956 Oct; 93(1):113-6. PubMed ID: 13370594
    [No Abstract]   [Full Text] [Related]  

  • 16. Concomitant adrenergic and parasympathetic fibres in the rat iris.
    Ehinger B; Falck B
    Acta Physiol Scand; 1966 Jun; 67(2):201-7. PubMed ID: 5963406
    [No Abstract]   [Full Text] [Related]  

  • 17. Sex differences following pharmacological manipulation of the cholinergic system by DFP and pilocarpine.
    Overstreet DH; Russell RW; Helps SC; Runge P; Prescott AM
    Psychopharmacology (Berl); 1979 Mar; 61(1):49-58. PubMed ID: 108719
    [No Abstract]   [Full Text] [Related]  

  • 18. [Histochemical and microanalytical studies of the behavior of adreno-cholinergic mediators].
    Tessitore V; Buscemi M; Costa V; Gerbino A
    Arch Ital Anat Embriol; 1981; 86(3):235-53. PubMed ID: 7344633
    [No Abstract]   [Full Text] [Related]  

  • 19. On the development of behavioral tolerance to organophosphates. III: Behavioral aspects.
    Wolthuis OL; Philippens IH; Vanwersch R
    Pharmacol Biochem Behav; 1990 Mar; 35(3):561-5. PubMed ID: 2339148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cafeteria behavior in the rat after hypothalamic cholinergic and adrenergic stimulation.
    Montgomery RB; Armstrong S
    Pharmacol Biochem Behav; 1975; 3(4):709-11. PubMed ID: 1187734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.